News

Henry Schein Announces Key Conference Call for 2024 Earnings

Henry Schein Announces Key Conference Call for 2024 Earnings

Overview of Henry Schein’s Upcoming Conference Call

Henry Schein, Inc. (Nasdaq: HSIC), recognized as the largest global provider of health care solutions tailored for dental and medical professionals, is gearing up to announce its financial results for the fourth quarter and the entire year of 2024. The company plans to release these results prior to the market opening on a scheduled Tuesday.

Details of the Earnings Conference Call

The earnings conference call is set to begin at 8:00 a.m. Eastern Time on the same day of the announcement. Stanley M. Bergman, the Chairman and CEO, will present alongside Ronald N. South, the Senior Vice President and CFO. Their insights are expected to cover key performance metrics and strategic developments impacting Henry Schein’s operations.

Where to Access the Call

Investors interested in the call can access it through Henry Schein’s official investor relations webpage, where a live webcast will be offered. A replay link will be made available post-presentation, allowing stakeholders to revisit the discussion and insights shared during the event.

Understanding Henry Schein’s Market Position

Henry Schein plays a pivotal role in supporting healthcare practitioners by delivering technology and operational solutions designed to enhance practice efficiency. Operating with a solid network of approximately 26,000 dedicated team members, the company serves over 1 million customers around the globe.

About the Company's Services

By offering more than 300 critical solutions spanning business, clinical, technology, and supply chain areas, Henry Schein enables dental and medical practitioners to provide quality care effectively. This comprehensive service model positions the company favorably to meet the growing demands of healthcare providers.

Financial Overview and Growth Trajectory

As a publicly traded entity since 1995, Henry Schein has cemented its status within the FORTUNE 500 and the S&P 500® index. With revenue reaching an impressive $12.3 billion in the previous fiscal year, the company has sustained a compound annual growth rate of approximately 11.5 percent. This growth illustrates Henry Schein’s stronghold in the evolving healthcare landscape.

Global Operations and Reach

Headquartered in Melville, N.Y., Henry Schein operates in 33 countries, offering a diverse array of healthcare products and services tailored for various healthcare settings, from dental offices to government clinics. Their centralized and automated distribution network ensures efficient delivery of more than 300,000 products, supporting healthcare professionals in providing critical care.

Continued Commitment to Quality and Innovation

Henry Schein's extensive product offering includes both branded and corporate brand items, designed to meet the diverse needs of healthcare providers. Their commitment to operational excellence and innovation drives the continuous improvement of healthcare delivery.

Frequently Asked Questions

1. What is the purpose of the upcoming conference call?

The conference call is intended to discuss Henry Schein's financial results for the fourth quarter and full year of 2024, along with insights regarding the company's future direction.

2. Who will be speaking during the conference call?

Stanley M. Bergman, Chairman and CEO, and Ronald N. South, Senior VP and CFO, will be the primary speakers providing updates and addressing investor inquiries.

3. How can I access the conference call?

Individuals can access the call via Henry Schein's investor relations website, where a live webcast will be available. A replay will also be provided after the event.

4. What position does Henry Schein hold in the healthcare market?

Henry Schein is recognized as the largest provider of health care solutions for dental and medical practitioners, giving it a significant foothold in the global healthcare market.

5. How has Henry Schein performed financially?

In the last fiscal year, Henry Schein reported sales of $12.3 billion and has experienced steady growth, maintaining a compound annual growth rate of around 11.5% since going public in 1995.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Anticipated Growth in Global Animal Feed Market Through 2028

Updated Category News Views 48

Expected Growth in the Global Animal Feed Market Through 2028 The global animal feed market is set for significant growth, with projections indicating an increase of USD 134.4 billion from 2024 to 2028. This remarkable expansion is driven by rising investments and advancements in production capabilities. Experts predict that the market will experience a compound annual...

Continue Reading
DIAGNOS Secures $2 Million in New Financing Led by Centurion One

Updated Category News Views 140

DIAGNOS Engages Centurion One Capital for Private Placement In a significant move, DIAGNOS Inc. is excited to announce its collaboration with Centurion One Capital Corp. as the exclusive lead agent for a brokered private placement. This initiative aims to raise around $2 million through the sale of up to an impressive 6,666,667 units of DIAGNOS at a set issue price of...

Continue Reading
First Quantum Minerals Achieves Resilience in Q4 2024

Updated Category News Views 370

First Quantum Minerals Reports Fourth Quarter Results (In United States dollars, except where noted otherwise) First Quantum Minerals Ltd. (TSX: FM) recently disclosed its financial performance for the fourth quarter of 2024, highlighting a net income of $99 million, equating to $0.12 earnings per share, along with adjusted earnings of $31 million or $0.04 per share....

Continue Reading
Markel Appoints Jamie Mullarkey as Global Officer for Underwriting

Updated Category News Views 51

Markel Welcomes Jamie Mullarkey Markel, a key player in the insurance industry, has made a noteworthy advancement by appointing Jamie Mullarkey as the Global Executive Underwriting Officer for Property and First Party Lines. This strategic decision underscores the company's dedication to leadership and innovation within its insurance operations. The Vision Behind the...

Continue Reading
eToro Announces Impressive Q3 2025 Results and Future Goals

Updated Category News Views 236

eToro Reports Strong Financial Growth for Third Quarter Leading trading and investing platform, eToro Group Ltd. (NASDAQ: ETOR), recently shared its promising financial performance for the third quarter. The report reveals that Net Contribution surged by an impressive 28% year-over-year, reaching $215 million, while Assets Under Administration rose a staggering 76% to hit...

Continue Reading